Chemours Co. (CC)

New York Stock Exchange:
CC
| Latest update: Mar 9, 2026, 6:39 PM

Price Chart

$16.37

0.22%
(1 month)

Top Shareholders

BlackRock, Inc.
17.26%
The Vanguard Group, Inc.
11.98%
State Street Corp.
4.10%
Ameriprise Financial, Inc.
3.01%
FMR LLC
2.72%
JPMorgan Chase & Co.
2.63%
The Goldman Sachs Group, Inc.
2.47%
UBS Group AG
2.44%

Sentiment for CC

News
Social

Buzz Talk for CC

Today

Social Media

General

Stock events for The Chemours Co. (CC)

Over the past six months, The Chemours Co. (CC) stock has trended up. Chemours reported its Fourth Quarter and Full Year 2025 results, including a Q4 2025 net loss of $47 million and a full-year net loss of $386 million, leading to a stock decline. The company announced a private offering of $600 million, later upsized to $700 million, of 7.875% Senior Notes Due 2034. Chemours agreed to an $875 million settlement with the State of New Jersey over 25 years to resolve environmental claims. Several analysts adjusted their price targets for Chemours.

Demand Seasonality affecting The Chemours Co.’s stock price

Demand seasonality varies across Chemours' product segments. Sales of fluorochemical refrigerants are seasonal, with higher demand in the first half of the year. There is no significant seasonality for fluoropolymers. The Titanium Technologies segment experiences seasonality, particularly in western markets, with sequential decreases in net sales in the third and fourth quarters.

Overview of The Chemours Co.’s business

The Chemours Co. is a global provider of performance chemicals, established in July 2015 as a spin-off from DuPont, operating in the Basic Materials sector. The company has three primary segments: Titanium Technologies (TT), which produces titanium dioxide (TiO2) pigment; Thermal & Specialized Solutions (TSS), which offers refrigerants and thermal management solutions; and Advanced Performance Materials (APM), which provides high-end polymers and advanced materials. Chemours also has a "Chemical Solutions" segment, which includes mining solutions and performance chemicals and intermediates.

CC’s Geographic footprint

Chemours has a significant global presence, operating 28 to 29 major production facilities in 8 to 9 countries. Its products are marketed across approximately 110 to 120 countries to a customer base of about 2,500 to 2,900. Key geographic regions include North America, Asia-Pacific, EMEA (Europe, Middle East, and Africa), and Latin America.

CC Corporate Image Assessment

The company's brand reputation in the past year has been significantly impacted by ongoing legal and environmental issues, particularly related to PFAS litigation. Chemours settled claims with the State of New Jersey for $875 million over 25 years to resolve environmental claims. The Pennsylvania Attorney General filed a lawsuit against Chemours and others for knowingly exposing the public to PFAS. Chemours emphasizes its commitment to sustainable innovation and its "Pathway to Thrive" strategy.

Ownership

The ownership structure of The Chemours Co. is predominantly institutional, with institutional investors holding approximately 94.20% of the company's shares. Major institutional owners include BlackRock, Inc., Vanguard Group Inc, State Street Corp, Ameriprise Financial Inc., Fmr Llc., and JPMorgan Chase & Co. Insider ownership stood at a modest 0.63%.

FAQ

What is the current stock price of The Chemours Co.?

As of the latest update, The Chemours Co.'s stock is trading at $16.37 per share.

What’s happening with The Chemours Co. stock today?

Today, The Chemours Co. stock is down by -0.22%, possibly due to news.

What is the market sentiment around The Chemours Co. stock?

Current sentiment around The Chemours Co. stock is positive, based on recent news, trading volume, and analyst opinions.

Is The Chemours Co.'s stock price growing?

Over the past month, The Chemours Co.'s stock price has decreased by -0.22%.

How can I buy The Chemours Co. stock?

You can buy The Chemours Co. stock through any brokerage platform, such as e.g., Robinhood, Fidelity, E*TRADE, by searching for the ticker symbol CC

Who are the major shareholders of The Chemours Co. stock?

Major shareholders of The Chemours Co. include institutions such as BlackRock, Inc. (17.26%), The Vanguard Group, Inc. (11.98%), State Street Corp. (4.10%) ... , according to the latest filings.